Summary: Everyone involved in MS research has their own reasons that make it important to them. My guest this week is Dr. Anisha Doshi, and Dr. Doshi's reasons are personal and powerful. You'll also hear Atara Biotherapeutics Chief Medical Officer Dr. AJ Joshi discuss Atara's clinical trial aimed at mitigating MS by using lab-engineered T-cells to attack B-cells carrying the Epstein-Barr Virus.
